| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9afcd0369d6402247555a4656c0917 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1977-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1980-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_887878a4d49366fbd7b2495d99f1946e |
| publicationDate |
1980-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4189492-A |
| titleOfInvention |
Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine |
| abstract |
Therapeutic antihypertensive compositions containing 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine or their non-toxic, pharmaceutically acceptable salts are described as well as a method of reducing blood pressure in mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4603141-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011097393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2363116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009158477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074429-B2 |
| priorityDate |
1977-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |